RBC Capital analyst Deane Dray lowered the firm’s price target on Ametek (AME) to $204 from $210 and keeps an Outperform rating on the shares. The company delivered a mostly in-line Q4 with seasonally solid free cash flows and robust $3.4B, but its 2025 guidance was light, the analyst tells investors in a research note. The company remains optimistic that both headwinds should ease as 2025 progresses however, and given AMETEK’s proven quality compounder model and attractive valuation, RBC remains positive on the stock, the firm added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AME:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue